MYLAN 531 (Sulindac 200 mg)
Pill imprint MYLAN 531 has been identified as Sulindac 200 mg.
Sulindac is used in the treatment of pain; osteoarthritis; ankylosing spondylitis; rheumatoid arthritis; gout, acute (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 531 (Sulindac 200 mg)
- 200 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0667||UDL Laboratories Inc|
|54569-4032||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
More about sulindac
- Other brands: Clinoril
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...